Cargando…

Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia

Accumulated genetic mutations are an important cause for the development of acute myeloid leukemia (AML), but abnormal changes in the inflammatory microenvironment also have regulatory effects on AML. Exploring the relationship between inflammatory response and pathological features of AML has impli...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Fang-Min, Yao, Fang-Yi, Liu, Jing, Zhang, Hai-Bin, Li, Mei-Yong, Jiang, Jun-Yao, Xu, Yan-Mei, Yang, Wei-Ming, Li, Shu-Qi, Zhang, Jing, Cheng, Ying, Xu, Shuai, Huang, Bo, Wang, Xiao-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093697/
https://www.ncbi.nlm.nih.gov/pubmed/35441668
http://dx.doi.org/10.1042/BSR20220647
_version_ 1784705389792591872
author Zhong, Fang-Min
Yao, Fang-Yi
Liu, Jing
Zhang, Hai-Bin
Li, Mei-Yong
Jiang, Jun-Yao
Xu, Yan-Mei
Yang, Wei-Ming
Li, Shu-Qi
Zhang, Jing
Cheng, Ying
Xu, Shuai
Huang, Bo
Wang, Xiao-Zhong
author_facet Zhong, Fang-Min
Yao, Fang-Yi
Liu, Jing
Zhang, Hai-Bin
Li, Mei-Yong
Jiang, Jun-Yao
Xu, Yan-Mei
Yang, Wei-Ming
Li, Shu-Qi
Zhang, Jing
Cheng, Ying
Xu, Shuai
Huang, Bo
Wang, Xiao-Zhong
author_sort Zhong, Fang-Min
collection PubMed
description Accumulated genetic mutations are an important cause for the development of acute myeloid leukemia (AML), but abnormal changes in the inflammatory microenvironment also have regulatory effects on AML. Exploring the relationship between inflammatory response and pathological features of AML has implications for clinical diagnosis, treatment and prognosis evaluation. We analyzed the expression variation landscape of inflammatory response-related genes (IRRGs) and calculated an inflammatory response score for each sample using the gene set variation analysis (GSVA) algorithm. The differences in clinical- and immune-related characteristics between high- and low-inflammatory response groups were further analyzed. We found that most IRRGs were highly expressed in AML samples, and patients with high inflammatory response had poor prognosis and were accompanied with highly activated chemokine-, cytokine- and adhesion molecule-related signaling pathways, higher infiltration ratios of monocytes, neutrophils and M2 macrophages, high activity of type I/II interferon (IFN) response, and higher expression of immune checkpoints. We also used the Genomics of Drug Sensitivity in Cancer (GDSC) database to predict the sensitivity of AML samples with different inflammatory responses to common drugs, and found that AML samples with low inflammatory response were more sensitive to cytarabine, doxorubicin and midostaurin. SubMap algorithm also demonstrated that high-inflammatory response patients are more suitable for anti-PD-1 immunotherapy. Finally, we constructed a prognostic risk score model to predict the overall survival (OS) of AML patients. Patients with higher risk score had significantly shorter OS, which was confirmed in two validation cohorts. The analysis of inflammatory response patterns can help us better understand the differences in tumor microenvironment (TME) of AML patients, and guide clinical medication and prognosis prediction.
format Online
Article
Text
id pubmed-9093697
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90936972022-05-19 Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia Zhong, Fang-Min Yao, Fang-Yi Liu, Jing Zhang, Hai-Bin Li, Mei-Yong Jiang, Jun-Yao Xu, Yan-Mei Yang, Wei-Ming Li, Shu-Qi Zhang, Jing Cheng, Ying Xu, Shuai Huang, Bo Wang, Xiao-Zhong Biosci Rep Bioinformatics Accumulated genetic mutations are an important cause for the development of acute myeloid leukemia (AML), but abnormal changes in the inflammatory microenvironment also have regulatory effects on AML. Exploring the relationship between inflammatory response and pathological features of AML has implications for clinical diagnosis, treatment and prognosis evaluation. We analyzed the expression variation landscape of inflammatory response-related genes (IRRGs) and calculated an inflammatory response score for each sample using the gene set variation analysis (GSVA) algorithm. The differences in clinical- and immune-related characteristics between high- and low-inflammatory response groups were further analyzed. We found that most IRRGs were highly expressed in AML samples, and patients with high inflammatory response had poor prognosis and were accompanied with highly activated chemokine-, cytokine- and adhesion molecule-related signaling pathways, higher infiltration ratios of monocytes, neutrophils and M2 macrophages, high activity of type I/II interferon (IFN) response, and higher expression of immune checkpoints. We also used the Genomics of Drug Sensitivity in Cancer (GDSC) database to predict the sensitivity of AML samples with different inflammatory responses to common drugs, and found that AML samples with low inflammatory response were more sensitive to cytarabine, doxorubicin and midostaurin. SubMap algorithm also demonstrated that high-inflammatory response patients are more suitable for anti-PD-1 immunotherapy. Finally, we constructed a prognostic risk score model to predict the overall survival (OS) of AML patients. Patients with higher risk score had significantly shorter OS, which was confirmed in two validation cohorts. The analysis of inflammatory response patterns can help us better understand the differences in tumor microenvironment (TME) of AML patients, and guide clinical medication and prognosis prediction. Portland Press Ltd. 2022-05-10 /pmc/articles/PMC9093697/ /pubmed/35441668 http://dx.doi.org/10.1042/BSR20220647 Text en © 2022 The Author(s). https://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Bioinformatics
Zhong, Fang-Min
Yao, Fang-Yi
Liu, Jing
Zhang, Hai-Bin
Li, Mei-Yong
Jiang, Jun-Yao
Xu, Yan-Mei
Yang, Wei-Ming
Li, Shu-Qi
Zhang, Jing
Cheng, Ying
Xu, Shuai
Huang, Bo
Wang, Xiao-Zhong
Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia
title Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia
title_full Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia
title_fullStr Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia
title_full_unstemmed Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia
title_short Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia
title_sort inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia
topic Bioinformatics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093697/
https://www.ncbi.nlm.nih.gov/pubmed/35441668
http://dx.doi.org/10.1042/BSR20220647
work_keys_str_mv AT zhongfangmin inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT yaofangyi inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT liujing inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT zhanghaibin inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT limeiyong inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT jiangjunyao inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT xuyanmei inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT yangweiming inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT lishuqi inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT zhangjing inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT chengying inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT xushuai inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT huangbo inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia
AT wangxiaozhong inflammatoryresponsemediatescrosstalkwithimmunefunctionandrevealsclinicalfeaturesinacutemyeloidleukemia